医学
阿利罗库单抗
急性冠脉综合征
内科学
心肌梗塞
心脏病学
载脂蛋白B
胆固醇
载脂蛋白A1
作者
Gregory G. Schwartz,Philippe Gabríel Steg,Michael Szarek,Deepak L. Bhatt,Vera Bittner,Rafael Díaz,Jay M. Edelberg,Shaun G. Goodman,Corinne Hanotin,Robert A. Harrington,J. Wouter Jukema,Guillaume Lecorps,Kenneth W. Mahaffey,Angèle Moryusef,Robert Pordy,Kirby Quintero,Matthew T. Roe,William J. Sasiela,Jean‐François Tamby,Pierluigi Tricoci
标识
DOI：10.1056/nejmoa1801174
摘要
Among patients who had a previous acute coronary syndrome and who were receiving high-intensity statin therapy, the risk of recurrent ischemic cardiovascular events was lower among those who received alirocumab than among those who received placebo. (Funded by Sanofi and Regeneron Pharmaceuticals; ODYSSEY OUTCOMES ClinicalTrials.gov number, NCT01663402 .).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
BowieHuang
Criminology34
ceeray23
优美紫槐
VDC
秀丽小猫咪
qing
领导范儿
无情的踏歌
andrele
小小
无极微光
yyds
嘿嘿
开放青旋
mmyhn
大龙哥886
lyncee
反恐分子
寻道图强
gaoyang
Owen
ZOE
帅气的安柏
皖公网安备34019202002308
